Training

Preconference and Postconference Training will be offered in conjunction with the 2008 Conference. Click here to Register!

 

Friday, 25 April 2008

Each session is 8:00 am - 5:00 pm (Lunch break 12:00 - 1:00 pm). Unless otherwise noted.



Advanced Training: Good Laboratory Practice

Session Chair: Jeanne deWard RQAP-GLP, Charles River Laboratories

Speakers:
James J. Carignan, Vital Bridge, Inc.
Jeanne deWard RQAP-GLP, Charles River Laboratories
Gregory Furrow, Charles River Laboratories
Guy H. Gardner RQAP-GLP, GlaxoSmithKline
James F. McCormack PhD, Charles River Laboratories Preclinical Services

Target Audience:
Quality Assurance professionals with two or more years of auditing experience in the GLP environment

Course Objectives:

  1. Build on knowledge of the GLP regulations to enhance auditing and inspecting skills
  2. Learn how to make audit reports more effective.
  3. Learn how to maximize the positive effects of FDA inspections

Course Description:
You know the GLPs and you have learned how to audit. What is the next level on the learning curve? This one-day session is devoted to interpreting the ‘short and simple’ GLPs in an increasingly complex environment, and becoming more effective in your role as the “Voice of GLP” in your workplace. The session will focus on different approaches for auditing data and final reports, “hot” or controversial topics in auditing, and tips for writing effective audit reports. We will explore approaches for managing FDA and EPA GLP inspections and ways to foster good relationships among sponsors, contractors and subcontractors. This session is intended for QA professionals with 2 years or more GLP experience.

 

Effective Value-Added Auditing for the 21st Century

Session Chair: William R. Kracht, Bill Kracht Consulting Services

Speaker: William R. Kracht, Bill Kracht Consulting Services

Target Audience:

While probably most beneficial for beginning and intermediate auditors, experienced / advanced auditors will gain some insights and ideas for improving their audit skills as well. In addition, those involved in the selection and/or training of auditors will find this course beneficial.

Course Objectives:

The attendee will be able to better understand and optimize the human relations aspects of auditing for maximum value in the results.

The attendee will be able to better understand and use the FDA concepts of system and process focus to optimize the effectiveness of both the audit program and individual audits.

The attendee will be able to more effectively apply the skills and processes of pre-audit, during-the-audit, and post-audit activities for maximum value to the organization.

Course Description:

This highly interactive course will focus on the skills and process of auditing, independent of the particular standard being audited. The main objective of the course will be to enhance the participant's ability to perform effective, objective, value-adding audits in any situation. Relevant class exercises, mini-case studies, etc. will be used throughout the course, including a pre-course “homework assignment.”


Principles of GMPs for the FDA Regulated Medical Industry

Session Chair: Howard T. Cooper, EQACT, Inc.

Speakers:
Raymond C. Anderson PhD, University of Arkansas for Medical Sciences
Howard T. Cooper, EQACT, Inc.
Gretchen Berry McAuliffe, EM2 Solutions, Inc.
Patrick Noland, ABC Laboratories, Inc.
David Rothkopf, MEDIcept, Inc.
Dennis Runser PhD, TMI Regulatory Compliance Consulting

Target Audience:
Quality professionals with all levels of experience will gain knowledge of the GMP regulations that apply throughout the medical industry. Other regulatory professionals will gain an insight into their own regulations and how they share common principles and objectives. All attendees will learn how the nature of the product determines the impact of the requirements of the regulations.”

Professionals working with combination products will particularly gain insight for more effective management of their product’s Good Manufacturing Practice requirements.

Course Objectives:
The attendee shall be able to:

  1. Understand the principles and objectives of the GMP regulations I
  2. Appreciate the flexibility of the GMP regulations to satisfy the stringent requirements of the medical products manufacturing environment
  3. Understand that the GMP regulations share common objectives and principles yet are designed with the flexibility to handle diverse product characteristics that have very demanding requirements.
  4. Learn regulatory and GMP terminology to improve understanding of GMP issues with other regulatory professionals
  5. Learn quality principles that are applicable to other regulatory disciplines outside the GMP arena

Course Description:
This course will demonstrate the principles and objectives of the GMP regulations. It will do this by:

  1. Describing & Explaining Regulatory and GMP Terminology
  2. Providing an overview of the principles and objectives common to all the GMP regulations
  3. Discussing differences between the GMP regulations
  4. Providing an overview of the following GMP regulations:
    • Drug Substance (Q7A)
    • Drug Product Part 210/211(Also FDA Guidance on the Quality Systems Approach to GMP)
    • FDA Guidance on Quality Systems Approach to Pharmaceutical CGMP Regulations
    • Medical Devices (Quality System Regulation) Part 820
    • Good Tissue Practices Part 1271

Understanding GxPs: Bridging the Communication Gap

Half-day Session, 8:00 am - 12:00 pm

Session Chair: Melissa Eitzen, MS, MT(ASCP), RQAP-GLP, University of Texas Medical Branch

Speakers:
Raymond C. Anderson PhD, University of Arkansas for Medical Sciences
James A. Ault RAC, RQAP-GLP, Ricerca Biosciences LLC
Howard T. Cooper, EQACT, Inc.
Nancy J. Gongliewski, GlaxoSmithKline
Celeste M. Gonzalez, Novartis Animal Health
Eric Humes RQAP-GLP, ICON Development Solutions

Target Audience:
This course is suitable for all QA professionals. Novice auditors will gain knowledge of the ‘big picture’ of the entire regulated process while also learning important terminology. Seasoned QA professionals who specialize in one area of the GxPs will gain an understanding and appreciation of the differences and commonalities of their colleagues who work in other specialty areas.

Course Objectives:
The attendee shall be able to:

  1. Appreciate regulatory specialty areas outside their scope of expertise
  2. Understand differences in terminology used within specialty areas
  3. Recognize commonalities and regulation overlaps between specialty areas
  4. Understand the regulatory framework
  5. Identify industry trends within specialty areas

Course Description:
The course is designed to broaden/promote a better understanding among QA professionals in order to improve communication among SQA members, sponsors, regulatory agencies, and CROs. The course includes an overview of the regulatory framework followed by presentations on the GLP, human GCP, veterinary GCP, GMP, and Good Tissue Practice (GTP) regulations. Course presentations are designed with a common matrix so that all speakers address regulation and auditing commonalities, differences, overlaps, and industry trends. Course materials will include a glossary of terms.

 

 

SQA Leadership Training

Half-day Session, 8:00 am - 12:00 pm

Complimentary for SQA Members

SQA will offer a special leadership training for volunteers within SQA. This training is complimentary for SQA members. If you currently volunteer for SQA or would like to become more involved, make plans to attend!

 

 

Click here for the preliminary meeting schedule

 

 

 
Useful Links